NCT01837043View on ClinicalTrials.gov

Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function

PHASE2UnknownINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Delayed Graft FunctionKidney Transplant
Interventions
DRUG

Belatacept

DRUG

Calcineurin Inhibitor

Trial Locations (1)

10029

RECRUITING

Mount Sinai School of Medicine Recanati/Miller Transplantation Institute, New York

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Nair, Vinay, D.O.

INDIV

NCT01837043 - Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function | Biotech Hunter | Biotech Hunter